Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s share price rose 1% during trading on Friday . The stock traded as high as $3.88 and last traded at $3.88. Approximately 709,358 shares changed hands during trading, an increase of 304% from the average daily volume of 175,661 shares. The stock had previously closed at $3.84.
Ono Pharmaceutical Trading Up 1.0 %
The stock has a fifty day moving average of $4.34 and a two-hundred day moving average of $4.60.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Read More
- Five stocks we like better than Ono Pharmaceutical
- 3 Warren Buffett Stocks to Buy Now
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- 3 Small Caps With Big Return Potential
- Top-Performing Non-Leveraged ETFs This Year
- Buy P&G Now, Before It Sets A New All-Time High
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
